1991
DOI: 10.1016/0003-4975(91)90918-g
|View full text |Cite
|
Sign up to set email alerts
|

Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
62
0
1

Year Published

1993
1993
2015
2015

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 170 publications
(63 citation statements)
references
References 21 publications
0
62
0
1
Order By: Relevance
“…Hypomagnesemia observed on 1 st POD is a relevant symptom preceding atrial fibrillation. [13] Hypomagnesemia is known to cause muscle weakness and respiratory failure. It is one factor causing difficulty in weaning the patient from ventilator.…”
Section: Discussionmentioning
confidence: 99%
“…Hypomagnesemia observed on 1 st POD is a relevant symptom preceding atrial fibrillation. [13] Hypomagnesemia is known to cause muscle weakness and respiratory failure. It is one factor causing difficulty in weaning the patient from ventilator.…”
Section: Discussionmentioning
confidence: 99%
“…10 -19 It is also attractive from a theoretical standpoint, because serum Mg levels have been shown to decline after cardiopulmonary bypass and do not recover to preoperative levels until 3 to 5 days after surgery, which coincides with the period during which most cases of AF develop. 11 Many small, randomized trials of MgSO 4 for prevention of AF have been published, and a recent meta-analysis concluded that MgSO 4 is an effective prophylactic agent for prevention of postoperative AF, 20 with the European Association for Cardiothoracic Surgery recommending prophylactic administration of IV MgSO 4 for prevention of postoperative AF in their recently published guidelines. 21 Regardless, we believe that there is still clinical equipoise regarding its routine use because the evidence comes from multiple small, underpowered trials, with conflicting results, probably because of differences in study design.…”
mentioning
confidence: 99%
“…Fanning et al [17] reported that the infusion of magnesium sulphate at the dose of 84 mmol/96 h reduced AF from 28% to 14.3% [17]; however, the decline was not statistically significant. Likewise, Jensen et al [18] demonstrated a non-statistical reduction in AF in patients treated with an infusion of 110 mmol Mg per 80 h [18].…”
Section: Discussionmentioning
confidence: 97%